Download PDF
Laryngorhinootologie 2008; 87: S1-S20
DOI: 10.1055/s-2007-995536
Früherkennung

© Georg Thieme Verlag KG Stuttgart · New York

Früherkennung von Kopf-Hals-Tumoren

Entwicklung, aktueller Stand und PerspektivenAndreas  O.  H.  Gerstner1
  • 1Klinik und Poliklinik für Hals-Nasen-Ohren-Heilkunde/Chirurgie, Universitätsklinikum Bonn
Further Information

Publication History

Publication Date:
28 March 2008 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Überleben und Lebensqualität bei den Krebserkrankungen im Kopf-Hals-Bereich hängen direkt von der Größe bei Erstdiagnose ab. Zusätzlich zur Primärprävention, bei der weitere Anstrengungen erforderlich sind, müssen die Möglichkeiten der Früherkennung verbessert werden. Allerdings fehlt es zum einen in Deutschland an der für ein erfolgreiches Screening erforderlichen Infrastruktur, zum anderen haben die bisher etablierten Untersuchungsverfahren eine zu niedrige Sensitivität und Spezifität. Die Fortschritte, die aktuell im Bereich der Endoskopietechnik, der Nachweismethoden und der Probengewinnung erzielt wurden, eröffnen jedoch Perspektiven im Bereich der Sekundärprävention. Mittels Chromoendoskopie und Narrowband Imaging können Schleimhautveränderungen leichter erkannt werden, mittels konfokaler Endomikroskopie und optischer Kohärenztomografie lassen sich optische „Schnitte” durch das Gewebe legen, und das hyperspektrale Imaging erlaubt eine Gewebsklassifikation anhand spektraler Signaturen. Diese Verfahren ermöglichen somit eine „optische Biopsie”. Auch die Palette der quantitativen und objektiven Parameter, die an minimal-invasiv gewonnenen Proben gemessen werden können, wurde größer und könnte die Grundlage für eine verlässliche Klassifikation der Schleimhautveränderungen sein (multiparametrische Zytometrie, quantitative Histologie). Schließlich könnten Ansätze der Proteomics und der Lab-on-the-Chip-Technologie eine bessere Identifikation der Hochrisikopatienten gewährleisten. Sensitivität und Spezifität all dieser Verfahren wurden jedoch noch nicht geprüft. Vor diesem Hintergrund und angesichts des ungeklärten Nutzen-Risiko-Verhältnisses sowohl für den Einzelnen als auch für die Solidargemeinschaft ist es jedoch bis zu einem Bevölkerungs-basierten Screeningprogramm noch ein weiter Weg.

Schlüsselwörter

Quantitative Histologie - Human Cytome Project - Hyperspectral Imaging - Optische Kohärenztomografie OCT

Literatur

  • 1 Essener Erklärung, Nationale Onkologische Präventionskonferenz N.O.P. 2007. Essen; http://www.praevention-krebs.de/downloads/essener_erklaerung.pdf (letzter Zugriff am 20. 12. 2007)
    Google Scholar
  • 2 Statistisches Bundesamt .DRG Statistik 2007.  https://www-ec.destatis.de/csp/shop/sfg/bpm.html.cms.cBroker.cls?cmspath=struktur,vollanzeige.csp&ID=1021166 (letzter Zugriff am 20. 12. 2007)
    Google Scholar
  • 3 Ahrens H J. Perspektiven der Prävention in Deutschland aus der Sicht der GKV. In: Kirch W, Badura B (Hrsg) Prävention. Berlin, Heidelberg; Springer 2006: 41-53
    Google Scholar
  • 4 Sackett D L. The arrogance of preventive medicine.  CMAJ. 2002;  167 263-264
    PubMedGoogle Scholar
  • 5 Mühlhauser I. Ist Vorbeugen besser als Heilen?.  Dtsch Ärztebl. 2007;  104 A1804-A1807
    PubMedGoogle Scholar
  • 6 Gøtzsche P C, Nielsen M. Screening for breast cancer with mammography.  Cochrane Database of Systematic Reviews. 2001;  4 Art. No.: CD001877. DOI: 10.1002/14651858.CD001877.pub2
    PubMedGoogle Scholar
  • 7 Farmer E R, Gonin R, Hanna M P. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists.  Hum Pathol. 1996;  27 528-531
    CrossrefPubMedGoogle Scholar
  • 8 Giersiepen K, Hense H W, Klug S J, Antes G, Zeeb H. Entwicklung, Durchführung und Evaluation von Programmen zur Krebsfrüherkennung - ein Positionspapier.  ZaeFQ. 2007;  101 43-49
    PubMedGoogle Scholar
  • 9 Beske F, Becker E, Krauss C, Katalinic A, Pritzkuleit R. Gesundheitsversorgung 2050. Kiel; Schmidt & Klaunig 2007
    Google Scholar
  • 10 Rabatta S. Sorge vor dem Gesundheitsgau.  Dtsch Ärztebl. 2007;  104 A2624
    PubMedGoogle Scholar
  • 11 Howard B V, Manson J E, Stefanick M L. et al . Low-fat dietary pattern and weight change over 7 years - the Women’s Health Initiative dietary modification trial.  JAMA. 2006;  295 39-49
    CrossrefPubMedGoogle Scholar
  • 12 Howard B V, Van Horn L, Hsia J. et al . Low-fat dietary pattern and risk of cardiovascular disease - the Women’s Health Initiative randomized controlled dietary modification trial.  JAMA. 2006;  295 655-666
    CrossrefPubMedGoogle Scholar
  • 13 Prentice R L, Caan B, Chlebowski R T. et al . Low-fat dietary pattern and risk of invasive breast cancer - the Women’s Health Initiative randomized controlled dietary modification trial.  JAMA. 2006;  295 629-642
    CrossrefPubMedGoogle Scholar
  • 14 Jackson R D, LaCroix A Z, Gass M. et al . Calcium plus vitamin D supplementation and the risk of fractures.  N Engl J Med. 2006;  354 669-683
    CrossrefPubMedGoogle Scholar
  • 15 Petitti D. Commentary: Hormone replacement therapy and coronary heart disease: four lessons.  Int J Epidemiol. 2004;  33 461-463
    PubMedGoogle Scholar
  • 16 Steiner W. Krebsprävention und Früherkennung im oberen Aerodigestivtrakt - Ergebnisse und Konsequenzen zweier Erlanger Feldstudien.  Fortschr Med. 1984;  102 529-533
    PubMedGoogle Scholar
  • 17 Steiner W. Krebsfrüherkennung im Bereich der oberen Luft- und Speisewege.  HNO. 1993;  41 360-367, 497 - 503
    PubMedGoogle Scholar
  • 18 Ambrosch P. Screeninguntersuchungen zur Früherkennung von Karzinomen der oberen Luft- und Speisewege.  HNO. 1996;  44 609-611
    CrossrefPubMedGoogle Scholar
  • 19 Smart R S. Screening for cancer of the aerodigestive tract.  Cancer. 1993;  72 1061-1065
    CrossrefPubMedGoogle Scholar
  • 20 Barra S, Barón A E, Barzan L, Caruso G, Veronesi A, Talamini R, Comoretto R, Franceschi S. Patients compliance in an early detection program for upper aero-digestive tract tumours in north-eastern Italy.  Soz Praeventivmed. 1990;  35 159-163
    PubMedGoogle Scholar
  • 21 Talamini R, Barzan L, Franceschi S, Caruso G, Gasparin A, Comoretto R. Determinant in compliance with an early detection programme for cancer of the head and neck in north-eastern Italy.  Eur J Cancer B Oral Oncol. 1994;  30B 415-518
    PubMedGoogle Scholar
  • 22 Festinger L. A theory of cognitive dissonance. Evanston; Row, Peterson 1957
    Google Scholar
  • 23 Brehm J W. Increasing cognitive dissonance by a fait accompli.  J Abnorm Psychol. 1959;  58 379-382
    PubMedGoogle Scholar
  • 24 Case D O, Andrews J E, Johnson J D, Allard S L. Avoiding versus seeking: the relationship of information seeking to avoidance, blunting, coping, dissonance, and related concepts.  J Med Libr Assoc. 2005;  93 353-362
    PubMedGoogle Scholar
  • 25 McMaster C, Lee C. Cognitive dissonance in tobacco smokers.  Addict Behav. 1991;  16 349-353
    CrossrefPubMedGoogle Scholar
  • 26 Steckelberg A, Kasper J, Redegeld M, Mühlhauser I. Risk information-barrier to informed choice? A focus group study.  Soz Praventivmed. 2004;  49 375-380
    CrossrefPubMedGoogle Scholar
  • 27 Deutsche Krebshilfe .Sachstandserhebung „Krebs-Früherkennung 2005”.  http://www.krebshilfe.de/fileadmin/Inhalte/Downloads/PDFs/Sachstandsbericht-KFU.pdf (letzter Zugriff am 20. 12. 2007)
    Google Scholar
  • 28 Nationale Onkologische Präventionskonferenz .http://www.praevention-krebs.de/index.php (letzter Zugriff am 20. 12. 2007)
  • 29 GEKID in Zusammenarbeit mit dem RKI .Krebs in Deutschland, 5. Auflage. Saarbrücken; 2006. http://www.krebsregister.saarland.de/publikationen/PDF/KiD_2006_Internet-Version.pdf (letzter Zugriff am 20. 12. 2007)
    Google Scholar
  • 30 Stewart B W, Kleihues P (Hrsg). WHO World Cancer Report 2003. Lyon; IARC Press 2003
    Google Scholar
  • 31 Gourin C G, Podolksy R H. Racial disparities in patients with head and neck squamous cell carcinoma.  Laryngoscope. 2006;  116 1093-1106
    CrossrefPubMedGoogle Scholar
  • 32 Dost P, Talanow D D, Kaiser S, Hirche H, Jahnke K. Zum Zeitintervall zwischen Symptom- und Behandlungsbeginn bei Kopf- und Halstumoren.  HNO. 1996;  44 492-496
    CrossrefPubMedGoogle Scholar
  • 33 Koscielny S, Wagner C, Beleites E. Untersuchungen zum Intervall zwischen Erstsymptom und Behandlungsbeginn bei Patienten mit Kopf-Hals-Tumoren.  HNO. 1999;  47 551-555
    CrossrefPubMedGoogle Scholar
  • 34 Pitiphat W, Diehl S R, Laskaris G, Cartsos V, Douglass C W, Zavras A I. Factors associated with delay in the diagnosis of oral cancer.  J Dent Res. 2002;  81 192-197
    PubMedGoogle Scholar
  • 35 Maier H, Sennewald E (Hrsg). Risikofaktoren für Plattenepithelkarzinome im Kopf-Hals-Bereich - Ergebnisse der Heidelberger Fallkontrollstudien. Sankt Augustin; HVBG 1994
    Google Scholar
  • 36 Maier H, Dietz A, Gewelke U, Heller W D, Weidauer H. Tobacco and alcohol and the risk of head and neck cancer.  Clin Invest. 1992;  70 320-327
    PubMedGoogle Scholar
  • 37 Bundeszentrale für gesundheitliche Aufklärung .Förderung des Nichtrauchens bei Jugendlichen 2007. http://www.bmg.bund.de/nn_604 822/DE/Themenschwerpunkte/Drogen-und-Sucht/Tabak/bzga-ergebnisse;templateId=raw,property=publicationFile.pdf/bzga-ergebnisse.pdf (letzter Zugriff am 20. 12. 2007)
    Google Scholar
  • 38 Grønbæk M, Becker U, Johansen D, Tønnesen H, Jensen G, Sørensen T IA. Population based cohort study of the association between alcohol intake and cancer of the upper digestive tract.  BMJ. 1998;  317 844-848
    PubMedGoogle Scholar
  • 39 Maier H, Tisch M, Conradt C, Tisch M, Pötschke-Langer M. Alkoholgenuß und Krebs des oberen Aerodigestivtraktes bei Frauen.  Dtsch Med Wochenschr. 1999;  124 851-854
    PubMedGoogle Scholar
  • 40 Luce D, Guenel P, Leclerce A, Brugere J, Point D, Rodriguez J. Alcohol and tobacco consumption in cancer of the mouth, pharynx, and larynx: a study of 316 female patients.  Laryngoscope. 1988;  98 313-316
    PubMedGoogle Scholar
  • 41 Bundeszentrale für gesundheitliche Aufklärung .Alkoholkonsum der Jugendlichen in Deutschland 2004 - 2007.  http://www.bmg.bund.de/cln_041/nn_604240/DE/Themenschwerpunkte/Drogen-und-Sucht/Alkohol/bzga-bericht-11-6,templateId=raw,property=publicationFile.pdf/bzga-bericht-11-6.pdf (letzter Zugriff am 20. 12. 2007)
    Google Scholar
  • 42 Rosenquist K, Wennerberg J, Schildt E B, Bladström A, Hansson B G, Andersson G. Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden.  Acta Oto-Laryngologica. 2005;  125 1327-1336
    CrossrefPubMedGoogle Scholar
  • 43 Maier H, Tisch M, Enderle G, Dietz A, Weidauer H. Berufliche Exposition gegenüber Farben, Lacken und Lösungsmitteln und Krebsrisiko im Bereich des oberen Aerodigestivtraktes.  HNO. 1997;  45 905-908
    CrossrefPubMedGoogle Scholar
  • 44 Maier H, Tisch M, Dietz A, Conradt C. Arbeiter in der Bauindustrie - eine Höchstrisikogruppe für Krebserkrankungen des oberen Atmungs- und Verdauungstraktes?.  HNO. 1999;  47 730-736
    CrossrefPubMedGoogle Scholar
  • 45 Maier H, Tisch M. Beruf und Krebs im Kopf-Hals-Bereich.  HNO. 1999;  47 1025-1037
    CrossrefPubMedGoogle Scholar
  • 46 Becher H, Ramroth H, Ahrens W, Risch A, Schmezer P, Dietz A. Occupation, exposure to polycyclic aromatic hydrocarbons and laryngeal cancer risk.  Int J Cancer. 2005;  116 451-457
    CrossrefPubMedGoogle Scholar
  • 47 Wills J H. Nasal carcinomas in wood workers: a review.  J Occup Med. 1982;  24 526-530
    PubMedGoogle Scholar
  • 48 Pesch B, Pierl C B, Gebel M. et al . Occupational risks for adenocarcinoma.  Occup Environ Med. 2007;  epub ahead of print
    PubMedGoogle Scholar
  • 49 Donhuijsen K, Hattenberger S, Schroeder H G. Sinunasale Karzinome nach Holzstaubbelastung - morphologisches Spektrum an 160 Fällen.  Pathologe. 2004;  25 14-20
    CrossrefPubMedGoogle Scholar
  • 50 Shiboski C H, Schmidt B L, Jordan R CK. Tongue and tonsil carcinoma.  Cancer. 2005;  103 1843-1849
    CrossrefPubMedGoogle Scholar
  • 51 Dahlstrom R K, Little J A, Zafereo M E, Margaret Lung  M, Wie Q, Sturgis E M. Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study.  Head Neck. 2007;  epub ahead of print
    PubMedGoogle Scholar
  • 52 Wight R, Paleri V, Arullendran P. Current theories for the development of nonsmoking and nondrinking laryngeal carcinoma.  Curr Opin Otolaryngol Head Neck Surg. 2003;  11 73-77
    CrossrefPubMedGoogle Scholar
  • 53 León X, Rinaldo A, Saffiotti U, Ferlito A. Laryngeal cancer in non-smoking and non-drinking patients.  Acta Otolaryngol. 2004;  124 664-669
    CrossrefPubMedGoogle Scholar
  • 54 Dahlstrom R K, Adler-Storthz K, Etzel C J, Liu Z, Dillon L, El-Naggar A K, Spitz M R, Schiller J T, Wie Q, Sturgis E M. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis.  Clin Cancer Res. 2003;  9 2620-2626
    PubMedGoogle Scholar
  • 55 zur Hausen H. Papillomaviruses and cancer: from basic science to clinical application.  Nature Rev Cancer. 2002;  2 342-350
    CrossrefPubMedGoogle Scholar
  • 56 Löning T, Ikenberg H, Becker J, Gissmann L, Hoepfer I, zur Hausen H. Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papilloma virus type related DNA.  J Invest Dermatol. 1985;  84 417-420
    CrossrefPubMedGoogle Scholar
  • 57 Syrjänen S, Syrjänen K, Mäntyjärvi R, Collan Y, Kärjä J. Human papillomavirus DNA in squamous cell carcinomas of the larynx demonstrated by in situ DNA hybridization.  ORL J Otorhinol Relat Spec. 1987;  49 175-186
    PubMedGoogle Scholar
  • 58 Hammarstedt L, Lindquist D, Dahlstrand D, Romanitan M, Onelöv Dahlgren L, Joneberg J, Creson N, Lindholm J, Ye W, Dalianis T, Munck-Wikland E. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer.  Int J Cancer. 2006;  119 2620-2623
    CrossrefPubMedGoogle Scholar
  • 59 D’Souza G, Kreimer A R, Viscidi R, Pawlita M, Fakhry C, Koch W M, Westra W H, Gillison M L. Case-control study of human papillomavirus and oropharyngeal cancer.  N Engl J Med. 2007;  356 1944-1956
    CrossrefPubMedGoogle Scholar
  • 60 Klussmann J P, Weissenborn S J, Wieland U, Dries V, Kolligs J, Jungehuelsing M, Eckel H E, Dienes H P, Pfister H J, Fuchs P G. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas.  Cancer. 2001;  92 2875-2884
    CrossrefPubMedGoogle Scholar
  • 61 Ritchie J M, Smith E M, Summersgill K F, Hoffman H T, Wang D, Klussmann J P, Turek L P, Haugen T H. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx.  Int J Cancer. 2003;  104 336-344
    CrossrefPubMedGoogle Scholar
  • 62 Kreimer A R, Clifford G M, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review.  Cancer Epidemiol Biomarkers Prev. 2005;  14 467-475
    CrossrefPubMedGoogle Scholar
  • 63 Boeing H, Dietrich T, Hoffmann K. et al . Intake of fruits and vegetables and risk of cancer of the upper aero-digestive tract: the prospective EPIC-study.  Cancer Causes Control. 2006;  17 957-969
    PubMedGoogle Scholar
  • 64 Perry C F, Stevens M, Rabie I, Yarker M E, Cochrane J, Perry E, Traficante R, Coman W. Chemoprevention of head and neck cancer with retinoids - a negative result.  Arch Otolaryngol Head Neck Surg. 2005;  131 198-203
    CrossrefPubMedGoogle Scholar
  • 65 van Zandwijk N, Dalesio O, Pastorino U, de Vries N, van Tinteren H. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer.  J Natl Cancer Inst. 2000;  92 977-986
    CrossrefPubMedGoogle Scholar
  • 66 Hansemann D. Über asymmetrische Zelltheilung in Epithelkrebsen und deren biologische Bedeutung.  Arch Pathol Anat Physiol Klin Medicin. 1890;  119 299-326
    PubMedGoogle Scholar
  • 67 Boveri T. Ergebnisse über die Konstitution der chromatischen Substanz des Zellkerns. Jena; Fischer 1904
    Google Scholar
  • 68 Boveri T. Zur Frage der Entstehung maligner Tumore. Jena; Fischer 1914
    Google Scholar
  • 69 Hardy P A, Zacharias H. Reappraisal of the Hansemann-Boveri hypothesis on the origin of tumors.  Cell Biology International. 2005;  29 983-992
    CrossrefPubMedGoogle Scholar
  • 70 Feulgen R, Rosenbeck H. Mikroskopisch-chemischer Nachweis einer Nucleinsäure vom Typus der Thymonucleinsäure und die darauf beruhende elektive Färbung von Zellkernen in mikroskopischen Präparaten.  Hoppe-Seyler’s Zeitschr Physiol Chem. 1924;  135 203-248
    PubMedGoogle Scholar
  • 71 Caspersson T, Lomakka G, Svensson G, Säfström R. A versatile ultramicrospectrograph for multiple-line and surface scanning high resolution measurements employing automatized data analysis.  Exp Cell Res. 1955;  3 40-51
    PubMedGoogle Scholar
  • 72 Atkin N B, Richards B M. Deoxyribonucleic acid in human tumours as measured by microspectrophotometry of Feulgen stain: a comparison of tumours arising at different sites.  Brit J Cancer. 1956;  10 769-786
    PubMedGoogle Scholar
  • 73 Capersson O. Quantitative cytochemical studies on normal, malignant, pre-malignant and atypical cell populations from the human uterine cervix.  Acta Cytol. 1964;  8 45-60
    PubMedGoogle Scholar
  • 74 Steinbeck R G, Auer G U, Zetterberg A D. Reliability and significance of DNA measurements in interphase nuclei and division figures in histological sections.  Eur J Cancer. 1999;  35 787-795
    CrossrefPubMedGoogle Scholar
  • 75 Pitot H C, Goldsworthy T, Moran S. The natural history of carcinogenesis: implications of experimental carcinogenesis in the genesis of human cancer.  J Supramol Struct Cellul Biochem. 1981;  17 133-146
    PubMedGoogle Scholar
  • 76 Oshimura M, Barrett J C. Chemically induced aneuploidy in mammalian cells: mechansims and biological significance in cancer.  Environ Mutagen. 1986;  8 129-159
    CrossrefPubMedGoogle Scholar
  • 77 Walch A, Bink K, Gais P, Stangl S, Hutzer P, Aubele M, Mueller J, Hofler H, Werner M. Evaluation of c-erbB-2 overexpression and Her-2/neu gene copy number heterogeneity in Barrett’s adenocarcinoma.  Anal Cell Pathol. 2000;  20 25-32
    PubMedGoogle Scholar
  • 78 Vogelstein B, Kinzler K W. The multistep nature of cancer.  Trends Genet. 1993;  9 138-141
    CrossrefPubMedGoogle Scholar
  • 79 Pollack J R, Sorlie T, Perou C M, Rees C A, Jeffrey S S, Lonning P E, Tibshirani R, Botstein D, Borresen-Dale A L, Brown P O. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors.  Proc Natl Acad Sci USA. 2002;  99 12 963-12 968
    PubMedGoogle Scholar
  • 80 Vogel F, Motulsky A G. Human genetics: problems and approaches. New York; Springer Verlag 1986
    Google Scholar
  • 81 Lengauer C, Kinzler K W, Vogelstein B. Genetic instability in colorectal cancers.  Nature. 1997;  386 623-627
    CrossrefPubMedGoogle Scholar
  • 82 Tomlinson I, Bodmer W. Selection, the mutation rate and cancer: insuring that the tale does not wag the dog.  Nature Med. 1999;  5 11-12
    PubMedGoogle Scholar
  • 83 Cairns J. The origin of human cancers.  Nature. 1981;  289 353-357
    CrossrefPubMedGoogle Scholar
  • 84 Stock R P, Bialy H. The sigmoidal curve of cancer.  Nature Biotech. 2003;  21 13-14
    CrossrefPubMedGoogle Scholar
  • 85 Meijer G A. Chromosomes and cancer, Boveri revisited.  Cell Oncol. 2005;  27 273-275
    PubMedGoogle Scholar
  • 86 Duesberg P, Li R. Multistep carcinogenesis: a chain reaction of aneuploidizations.  Cell Cycle. 2002;  2 202-210
    PubMedGoogle Scholar
  • 87 Duesberg P, Li R, Fabarius A, Hehlmann R. The chromosomal basis of cancer.  Cell Oncol. 2005;  27 293-318
    PubMedGoogle Scholar
  • 88 Barnes L, Eveson J W, Reichart P, Sidransky D (Hrsg). WHO Classification of Tumours, Pathology and Genetics of Head and Neck Tumours. Lyon; IARC Press 2005
    Google Scholar
  • 89 O’Shaughnessy J A, Kelloff G J, Gordon G B. et al . Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.  Clin Cancer Res. 2002;  8 314-346
    PubMedGoogle Scholar
  • 90 Neville B M, Day T A. Oral cancer and precancerous lesions.  CA Cancer J Clin. 2002;  52 195-215
    PubMedGoogle Scholar
  • 91 Schwimmer E. Die idiopathischen Schleimhautplaques der Mundhöhle (Leukoplakia buccalis).  Arch Dermat Syph. 1877;  9 570-611
    PubMedGoogle Scholar
  • 92 Kramer I R, Lucas R B, Pindborg JJ, Sobin L H. WHO collaborating centre for oral precancerous lesions - definition of leukoplakia and related lesions: an aid to studies on oral precancer.  Oral Surg Oral Med Oral Pathol. 1978;  46 518-539
    CrossrefPubMedGoogle Scholar
  • 93 Queyrat L. Erythroplasie de gland.  Bull Soc Franc Derm Syph. 1911;  22 378-382
    PubMedGoogle Scholar
  • 94 Shafer W G, Waldron C A. Erythroplakia of the oral cavity.  Cancer. 1975;  36 1021-1028
    CrossrefPubMedGoogle Scholar
  • 95 LiVolsi V A. Can we agree to disagree?.  Hum Pathol. 2003;  34 1081-1082
    CrossrefPubMedGoogle Scholar
  • 96 Ackerman A B. Can we agree to disagree - reflexions.  Hum Pathol. 2004;  35 643-644
    CrossrefPubMedGoogle Scholar
  • 97 Foucar E. Diagnostic precision and accuracy in interpretation of specimens from cancer screening programs.  Semin Diagn Pathol. 2005;  22 147-155
    CrossrefPubMedGoogle Scholar
  • 98 Fischer D J, Epstein J B, Morton T H, Schwartz S M. Interobserver reliability in the histopathologic diagnosis of oral pre-malignant and malignant lesions.  J Oral Pathol Med. 2004;  33 65-70
    CrossrefPubMedGoogle Scholar
  • 99 Kujan O, Khattab A, Oliver R J, Roberts S A, Thakker N, Sloan P. Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: an attempt to understand the sources of variation.  Oral Oncol. 2007;  43 224-231
    CrossrefPubMedGoogle Scholar
  • 100 McLaren K M, Burnett R A, Goodlad J R. et al . Consistency of histopathological reporting of laryngeal dysplasia - the Scottish pathology consistency group.  Histopathology. 2000;  37 460-463
    CrossrefPubMedGoogle Scholar
  • 101 Lessells A M, Burnett R A, Goodlad J R. et al . Comment on a recent paper and editorial on the subject of dysplasia classification.  J Pathol. 2002;  198 131-132
    PubMedGoogle Scholar
  • 102 Montgomery E. Is there a way for pathologists to decrease interobserver variability in the diagnosis of dysplasia?.  Arch Pathol Lab Med. 2005;  129 174-176
    PubMedGoogle Scholar
  • 103 Morgenroth K. Über die Früherkennung maligner Veränderungen der Mundschleimhaut.  Zahnärztl Mitt. 1969;  59 341-344
    PubMedGoogle Scholar
  • 104 Kränzl B, Sorgo E, Wutka P. Untersuchung zur Anwendbarkeit der Zytodiagnostik für die Früherkennung von Mundhöhlenkrebs an der Klinik für Mundchirurgie.  Wien Klin Wochenschr. 1974;  86 648-650
    PubMedGoogle Scholar
  • 105 Wächter R. Technik und Indikationen der Zytodiagnostik für die Krebsfrüherkennung.  SSO Schweiz Monatsschr Zahnheilk. 1978;  88 829-836
    PubMedGoogle Scholar
  • 106 McLeod N MH, Saeed N R, Ali E A. Oral cancer: Delays in referral and diagnosis persist.  Br Dent J. 2005;  198 681-684
    PubMedGoogle Scholar
  • 107 Mignogna M D, Fedele S, Lo Russo L, Ruoppo E, Lo Muzio L. Oral and pharyngeal cancer: lack of prevention and early detection by health care providers.  Eur J Cancer Prev. 2001;  10 381-383
    CrossrefPubMedGoogle Scholar
  • 108 Kujan O, Glenny A M, Oliver R J, Thakker N, Sloan P. Screening programmes for the early detection and prevention of oral cancer.  Cochrane Database of Systematic Reviews. 2006;  3 Art. No.: CD004150. DOI: 10.1002/14651858.CD004150.pub2
    PubMedGoogle Scholar
  • 109 Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, Rajan B. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial.  Lancet. 2005;  365 1927-1933
    CrossrefPubMedGoogle Scholar
  • 110 Dalcq A. Vital staining with toluidine blue and its metachromatic manifestations.  C R Seances Soc Biol Fil. 1952;  146 1408-1411
    PubMedGoogle Scholar
  • 111 Little J W. Toluidine blue staining in the detection of oral precancerous and malignant lesions.  Oral Surg Oral Med Oral Pathol. 1984;  57 379-382
    CrossrefPubMedGoogle Scholar
  • 112 Gupta A, Singh M, Ibrahim R, Mehrotra R. Utility of toluidine blue staining and brush biopsy in precancerous and cancerous oral lesions.  Acta Cytol. 2007;  51 788-794
    PubMedGoogle Scholar
  • 113 Du G F, Li C Z, Chen H Z, Chen X M, Xiao Q, Cao Z G, Shang S H, Cai X. Rose bengal staining in detection of oral precancerous and malignant lesions with colorimetric evaluation: a pilot study.  Int J Cancer. 2007;  120 1958-1963
    CrossrefPubMedGoogle Scholar
  • 114 Farah C S, McCullough M J. A pilot case control study on the efficacy of acetic wash and chemiluminescent illumination (ViziLite®) in the visualisation of oral mucosal white lesions.  Oral Oncol. 2007;  43 820-824
    CrossrefPubMedGoogle Scholar
  • 115 Oh E S, Laskin D M. Efficacy of the ViziLite® system in the identification of oral lesions.  J Oral Maxillofac Surg. 2007;  65 424-426
    CrossrefPubMedGoogle Scholar
  • 116 Ram S, Siar C H. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions.  Int J Oral Maxillofac Surg. 2005;  34 521-527
    CrossrefPubMedGoogle Scholar
  • 117 Epstein J B, Silverman Jr S, Epstein J D, Lonky S A, Bride M A. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue.  Oral Oncol. 2007;  epub ahead of print
    PubMedGoogle Scholar
  • 118 Policard A. Etude sur les aspects offerts par des tumeurs experimentales examinées a la lumière de Wood.  C R Soc Biol. 1924;  91 1423-1424
    PubMedGoogle Scholar
  • 119 Lipson R L, Baldes J E, Olsen A M. Hematoporphyrin derivative: a new aid for endoscopic detection of malignant tissue.  J Thorac Cardiovasc Surg. 1962;  42 623-629
    PubMedGoogle Scholar
  • 120 Delank W, Khanavkar B, Nakhosteen J A, Stoll W. A pilot study of autofluorescent endoscopy for the in vivo detection of laryngeal cancer.  Laryngoscope. 2000;  110 368-373
    PubMedGoogle Scholar
  • 121 Arens C, Reussner D, Woenkhaus J, Leunig A, Betz C S, Glanz H. Indirect fluorescence laryngoscopy in the diagnosis of precancerous and cancerous laryngeal lesions.  Eur Arch Otorhinolaryngol. 2007;  264 621-626
    CrossrefPubMedGoogle Scholar
  • 122 Svistun E, Alizadeh-Naderi E, El-Naggar A, Jacob R, Gillenwater A, Richards-Kortum R. Vision enhancement system for detection of oral cavity neoplasia based on autofluorescence.  Head Neck. 2004;  26 205-215
    CrossrefPubMedGoogle Scholar
  • 123 Zengyk H, Weissz A, Clinex R, MacAulayy C E. Real-time endoscopic fluorescence imaging for early cancer detection in the gastrointestinal tract.  Bioimaging. 1998;  6 151-165
    CrossrefPubMedGoogle Scholar
  • 124 Rasetti L, Rubino G, Drago W. Ferrochelatase, ALA-dehydrase and ALA-synthetase activity in human tumor tissue.  Minerva Med. 1966;  57 2834-2837
    PubMedGoogle Scholar
  • 125 Leunig A, Betz C S, Heinrich P, Janda P, Baumgartner R. Fluoreszenzdiagnostik von Karzinomen im Mund-Rachen-Kehlkopf-Bereich nach Applikation von 5-Aminolävulinsäure.  Laryngo-Rhino-Otol. 2002;  81 807-814
    PubMedGoogle Scholar
  • 126 Leunig A, Betz C S, Mehlmann M, Stepp H, Arbogast S, Grevers G, Baumgartner R. Detection of squamous cell carcinoma of the oral cavity by imaging 5-aminolevulinic acid-induced protoporphyrin IX fluorescence.  Laryngoscope. 2000;  110 78-83
    PubMedGoogle Scholar
  • 127 Mao L, Lee J S, Fan Y H, Ro J Y, Batsakis J G, Lippman S, Hittelman W, Hong W K. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment.  Nature Med. 1996;  2 682-685
    PubMedGoogle Scholar
  • 128 Rosin M P, Cheng X, Poh C. et al . Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.  Clin Cancer Res. 2000;  6 357-362
    PubMedGoogle Scholar
  • 129 Ha P K, Pai S I, Westra W H, Gillison M L, Tong B C, Sidransky D, Califano J A. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity.  Clin Cancer Res. 2002;  8 1203-1209
    PubMedGoogle Scholar
  • 130 Herrero R, Castellsagué X, Pawlita M. et al . Human papillomavirus and oral cancer: the international agency for research on cancer multicenter study.  J Natl Cancer Inst. 2003;  95 1772-1783
    CrossrefPubMedGoogle Scholar
  • 131 Hullmann M, Reichert T, Dahse R, von Eggeling F, Pistner H, Kosmehl H, Driemel O. Orale Zytologie - historische Entwicklung, aktueller Stand und Ausblick.  Mund Kiefer Gesichts Chir. 2007;  11 1-9
    PubMedGoogle Scholar
  • 132 Koburg E, Steinbach E. Toluidinblau-Vitalfärbung zur Früherkennung und Abgrenzung maligner Kehlkopftumoren.  Eur Arch Otorhinolaryngol. 1969;  194 320-323
    PubMedGoogle Scholar
  • 133 Olofsson J. Laryngeal carcinoma: problems in diagnosis and classification.  J Otolaryngol. 1982;  11 167-177
    PubMedGoogle Scholar
  • 134 Harries M L, Lam S, Macaulay C, Qu J A, Palcic B. Diagnostic imaging of the larynx: autofluorescence of laryngeal tumors using the helium-cadmium laser.  J Laryngol Otol. 1995;  109 108-110
    PubMedGoogle Scholar
  • 135 Arens C, Malzahn K, Dias O, Andrea M, Glanz H. Endoskopische Bildgebung in der Diagnostik von Kehlkopfkrebs und seiner Vorstufen.  Laryngorhinootolgie. 1999;  78 685-691
    PubMedGoogle Scholar
  • 136 Žargi M, Fajdiga I, Šmid L. Autofluorescence imaging in the diagnosis of laryngeal cancer.  Eur Arch Otorhinolaryngol. 2000;  257 17-23
    PubMedGoogle Scholar
  • 137 Malzahn K, Dreyer T, Glanz H, Arens C. Autofluorescence endoscopy in the diagnosis of early laryngeal cancer and its precursor lesions.  Laryngoscope. 2002;  112 488-493
    CrossrefPubMedGoogle Scholar
  • 138 Arens C, Dreyer T, Glanz H, Malzahn K. Indirect autofluorescence laryngoscopy in the diagnosis of laryngeal cancer and its precursor lesions.  Eur Arch Otorhinolaryngol. 2004;  261 71-76
    PubMedGoogle Scholar
  • 139 Mehlmann M, Betz C S, Stepp H, Arbogast S, Baumgartner R, Grevers G, Leunig A. Fluorescence staining of laryngeal neoplasms after topical application of 5-aminolevulinic acid: preliminary results.  Lasers Surg Med. 1999;  25 414-420
    CrossrefPubMedGoogle Scholar
  • 140 Franco Jr R A. Aminolevulinic acid 585nm pulsed dye laser photodynamic treatment of laryngeal keratosis with atypia.  Otolaryngol Head Neck Surg. 2007;  136 882-887
    CrossrefPubMedGoogle Scholar
  • 141 Hoffman H AT, Karnell L H, Shah J P, Ariyan S, Brown G S, Fee W E, Glass A G, Goepfert H, Ossoff R H, Fremgen A M. Hypopharyngeal cancer patient care evaluation.  Laryngoscope. 1997;  107 1005-1017
    PubMedGoogle Scholar
  • 142 Zhou L, Cheng L, Tao L, Jia X, Lu Y, Liao P. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.  Acta Oto-Laryngologica. 2006;  126 853-860
    CrossrefPubMedGoogle Scholar
  • 143 Eckel H E, Staar S, Volling P, Sittel C, Damm M, Jungehülsing M. Surgical treatment for hypopharynx carcinoma: feasibility, mortality, and results.  Otolaryngol Head Neck Surg. 2001;  124 561-569
    CrossrefPubMedGoogle Scholar
  • 144 Watanabe A, Hosokawa M, Taniguchi M, Tsujie H, Sasaki S. Impact of endoscopic screening on early detection of hypopharyngeal cancer.  Head Neck. 2006;  28 350-354
    CrossrefPubMedGoogle Scholar
  • 145 Pinkston J A, Cole P. Incidence rates of salivary gland tumors: results from a population-based study.  Otolaryngol Head Neck Surg. 1999;  120 834-840
    CrossrefPubMedGoogle Scholar
  • 146 Belsky J L, Takeichi N, Yamamoto T, Cihak R W, Hirose F, Ezaki H, Inoue S, Blot W J. Salivary gland neoplasms following atomic radiation: additional cases and reanalysis of combined data in a fixed population, 1957-1970.  Cancer. 1975;  35 555-559
    CrossrefPubMedGoogle Scholar
  • 147 Mihailescu D, Shore-Freedman E, Mukani S, Lubin J, Ron E, Schneider A B. Multiple neoplasms in an irradiated cohort: pattern of occurrence and relationship to thyroid cancer outcome.  J Clin Endocrinol Metab. 2002;  87 3236-3241
    CrossrefPubMedGoogle Scholar
  • 148 Hoffman D A, McConahey W M, Fraumeni Jr J F, Kurland L T. Cancer incidence following treatment of hyperthyroidism.  Int J Epidemiol. 1982;  11 218-224
    CrossrefPubMedGoogle Scholar
  • 149 Auvinen A, Hietanen M, Luukkonen R, Koskela R S. Brain tumors and salivary gland cancers among cellular telephone users.  Epidemiology. 2002;  13 356-359
    CrossrefPubMedGoogle Scholar
  • 150 Horn-Ross P L, Ljung B M, Morrow M. Environmental factors and the risk of salivary gland cancer.  Epidemiology. 1997;  8 414-419
    CrossrefPubMedGoogle Scholar
  • 151 Milham Jr S. Cancer mortality pattern associated with exposure to metals.  Ann N Y Acad Sci. 1976;  271 243-249
    CrossrefPubMedGoogle Scholar
  • 152 Dietz A, Barme B, Gewelke U, Sennewald E, Heller W D, Maier H. Zur Epidemiologie der Parotistumoren - eine Fallkontrollstudie.  HNO. 1993;  41 83-90
    PubMedGoogle Scholar
  • 153 Swanson G M, Burns P B. Cancers of the salivary gland: workplace risks among women and men.  Ann Epidemiol. 1997;  7 369-374
    CrossrefPubMedGoogle Scholar
  • 154 Muscat J E, Wynder E L. A case/control study of risk factors for major salivary gland cancer.  Otolaryngol Head Neck Surg. 1998;  118 195-198
    CrossrefPubMedGoogle Scholar
  • 155 Droese M, Haubrich J, Tute M. Stellenwert der Punktionszytologie in der Diagnostik der Speicheldrüsentumoren.  Schweiz Med Wochenschr. 1978;  108 933-935
    PubMedGoogle Scholar
  • 156 Knapp I, Mann W, Wachter W. Stellenwert der ultraschallgesteuerten Feinnadelbiopsie in der Diagnostik unklarer Halstumoren.  Laryngo Rhino Otol. 1989;  68 683-689
    PubMedGoogle Scholar
  • 157 Siegert R, Schrader B, Barreton G. Die ultraschallgeführte Feinnadelpunktion pathologischer Raumforderungen im Kopf-Halsbereich.  HNO. 1990;  38 287-291
    PubMedGoogle Scholar
  • 158 Schoengen A, Binder T, Krause H R, Stussak G, Zeelen U. Der Wert der Feinnadelaspirationszytologie bei tumorverdächtigen Speicheldrüsenschwellungen.  HNO. 1995;  43 239-243
    PubMedGoogle Scholar
  • 159 Zbären P, Schar C, Hotz M A, Loosli H. Value of fine-needle aspiration cytology of parotid gland masses.  Laryngoscope. 2001;  111 1989-1992
    CrossrefPubMedGoogle Scholar
  • 160 Schröder U, Eckel H E, Rasche V, Arnold G, Ortmann M, Stennert E. Wertigkeit der Feinnadelpunktionszytologie bei Neoplasien der Glandula parotis.  HNO. 2000;  48 421-429
    CrossrefPubMedGoogle Scholar
  • 161 Driemel O, Kraft K, Hemmer J. DNA-Ploidie und proliferative Aktivität bei Speicheldrüsentumoren.  Mund Kiefer GesichtsChir. 2007;  11 139-144
    CrossrefPubMedGoogle Scholar
  • 162 Driemel O, Kraft K, Hemmer J. Flow cytometric S-phase fraction contributes to diagnosis of diploid malignant salivary gland tumours.  Int J Oral Maxillofac Surg. 2006;  35 947-950
    CrossrefPubMedGoogle Scholar
  • 163 Driemel O, Maier H, Kraft K, Haase S, Hemmer J. Flow cytometric DNA ploidy in salivary gland tumors.  Oncol Rep. 2005;  13 161-165
    PubMedGoogle Scholar
  • 164 Slaughter D P, Southwick H W, Smejkal W. „Field cancerization” in oral stratified squamous epithelium - clinical implications of multicentric origin.  Cancer. 1953;  6 963-968
    CrossrefPubMedGoogle Scholar
  • 165 Hao S P. Six primary squamous cell carcinomas of the head and neck.  Auris Nasus Larynx. 1998;  25 101-104
    CrossrefPubMedGoogle Scholar
  • 166 Braakhuis B JM, Brakenhoff R H, Leemans C R. Second field tumors: a new opportunity for cancer prevention?.  Oncologist. 2005;  10 493-500
    CrossrefPubMedGoogle Scholar
  • 167 Warren S, Gates O. Multiple primary malignant tumors. A survey of the literature and a statistical study.  Am J Cancer. 1932;  16 1358-1414
    PubMedGoogle Scholar
  • 168 Shikhani A H, Matanoski G M, Jones M M, Kashima H K, Johns M E. Multiple primary malignancies in head and neck cancer.  Arch Otolaryngol Head Neck Surg. 1986;  112 1172-1179
    PubMedGoogle Scholar
  • 169 Shaha A R, Hoover E L, Mitrani M, Marti J R, Krespi Y P. Synchronicity, multicentricity, and metachronicity of head and neck cancer.  Head Neck Surg. 1988;  10 225-228
    PubMedGoogle Scholar
  • 170 Panosetti E, Luboinski B, Mamelle G, Richard J M. Multiple synchronous and metachronous cancers of the upper aerodigestive tract: a nine-year study.  Laryngoscope. 1989;  99 1267-1273
    PubMedGoogle Scholar
  • 171 Schwartz L H, Ozsahin M, Zhang G N, Touboul E, de Vafaire F, Andolenko P, Lacau-Saint-Guily J, Lnugier A, Schlienger M. Synchronous and metachronous head and neck carcinomas.  Cancer. 1994;  74 1933-1938
    CrossrefPubMedGoogle Scholar
  • 172 Jäckel M C, Martin A, Steiner W. Lokale und regionäre Rezidive von laserchirurgisch behandelten Plattenepithelkarzinomen des oberen Aerodigestivtrakts - Häufigkeit, Latenz und Prognose sowie Einfluss der initialen Tumorparameter.  HNO. 2007;  epub ahead of print
    PubMedGoogle Scholar
  • 173 Gao X, Fisher S G, Mohideen N, Emami B. Second primary cancers in patients with laryngeal cancer: a population-based study.  Int J Radio Oncol Biol Phys. 2003;  56 427-435
    PubMedGoogle Scholar
  • 174 Gleich L L, Ryzenman J, Gluckman J L, Wilson K M, Barrett W L, Redmond K P. Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: is salvage possible?.  Arch Otolaryngol Head Neck Surg. 2004;  130 35-38
    CrossrefPubMedGoogle Scholar
  • 175 Glanz H. Late recurrence of radiation induced cancer of the larynx.  Clin Otolaryngol Allied Sci. 1976;  1 123-129
    PubMedGoogle Scholar
  • 176 Martin G, Glanz H, Kleinsasser O. Ionisierende Strahlen und Kehlkopfkrebse.  Laryngo Rhino Otol. 1979;  58 187-195
    PubMedGoogle Scholar
  • 177 Roostaeian J, Suh J D, Sercarz J A, Abemayor E, Lee J T, Blackwell K E. Factors affecting cancer recurrence after microvascular flap reconstruction of the head and neck.  Laryngoscope. 2005;  115 1391-1394
    Google Scholar
  • 178 Scherübl H, Steinberg J, Schwertner C, Mir-Salim P, Stölzel U, de Villiers E M. „Field cancerization” im oberen Aerodigestivtrakt - Überwachungsempfehlungen für Risikopersonen.  HNO. 2007;  epub ahead of print
    PubMedGoogle Scholar
  • 179 Watanabe A, Hosokawa M, Taniguchi M, Sasaki S. Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer.  Ann Thorac Surg. 2003;  76 1699-1705
    CrossrefPubMedGoogle Scholar
  • 180 Möschler O, Spahn T W, Middelberg-Bisping C, Grosse-Thie W, Christoph B, Kloeppel G, Mueller MK. Chromoendoscopy is a valuable tool for screening of high-risk patients with head and neck cancer for early detection of esophageal cancer.  Digestion. 2006;  73 160-166
    CrossrefPubMedGoogle Scholar
  • 181 Merkx M AW, van Gulick J JM, Marres H AM, Kaanders J HAM, Bruaset J, Verbeek A, de Wilde P CM. Effectiveness of routine follow-up of patients treated for T1 - 2 N0 oral squamous cell carcinomas of the floor of mouth and tongue.  Head Neck. 2006;  28 1-7
    CrossrefPubMedGoogle Scholar
  • 182 de Visscher A V, Manni J J. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity - does it make sense?.  Arch Otolaryngol Head Neck Surg. 1994;  120 934-939
    PubMedGoogle Scholar
  • 183 Rassekh C H, Johnson J T, Eibling D E. Circulating markers in squamous cell carcinoma of the head and neck: a review.  Eur J Cancer B Oral Oncol. 1994;  30B 23-28
    PubMedGoogle Scholar
  • 184 Tannapfel A, Weber A. Tumor markers in squamous cell carcinoma of the head and neck: clinical effectiveness and prognostic value.  Eur Arch Otorhinolaryngol. 2001;  258 83-88
    CrossrefPubMedGoogle Scholar
  • 185 Brown J J, Xu H, Nishitani J, Mohammed H, Osborne R, Teklehaimanot S, Gill G, Liu X. Potential biomarkers for head and neck squamous cell carcinoma.  Laryngoscope. 2003;  113 393-400
    CrossrefPubMedGoogle Scholar
  • 186 Nagler R M, Barak M, Peled M, Ben-Aryeh H, Filatov M, Laufer D. Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21 - 1 and TPS in oral squamous cell carcinoma.  Cancer. 1999;  85 1018-1025
    CrossrefPubMedGoogle Scholar
  • 187 Doweck I, Barak M, Uri N, Greenberg E. The prognostic value of the tumour marker Cyfra 21 - 1 in carcinoma of head and neck and its role in early detection of recurrent disease.  Br J Cancer. 2000;  83 1696-1701
    CrossrefPubMedGoogle Scholar
  • 188 Arlt A, Luckhaupt H, Hildmann H. Diagnostik von Kopf-Hals-Karzinom-Rezidiven mit dem Tumormarker SSC-Antigen.  Laryngo Rhino Otol. 2000;  79 207-212
    PubMedGoogle Scholar
  • 189 Welkoborsky H J, Bernauer H S, Riazimand H S, Jacob R, Mann W J, Hinni M L. Patterns of chromosomal aberrations in metastasizing and nonmetastasizing squamous cell carcinomas of the oropharynx and hypopharynx.  Ann Otol Rhinol Laryngol. 2000;  109 401-410
    PubMedGoogle Scholar
  • 190 Beyer T, Townsend D W, Brun T, Kinahan P E, Charron M, Roddy R, Jerin J, Young J, Byars L, Nutt R. A combined PET/CT scanner for clinical oncology.  J Nucl Med. 2000;  41 1369-1379
    PubMedGoogle Scholar
  • 191 Gordin A, Daitzchman M, Doweck I, Yefremov N, Golz A, Keidar Z, Bar-Shalom R, Kuten A, Israel O. Fluorodeoxyglucose-positron emission tomography/computed tomography imaging in patients with carcinoma of the larynx: diagnostic accuracy and impact on clinical management.  Laryngoscope. 2006;  116 273-278
    CrossrefPubMedGoogle Scholar
  • 192 Brouwer J, Senft A, de Bree R, Comans E F, Golding R P, Castelijns J A, Hoekstra O S, Leemans C R. Screening for distant metastases in patients with head and neck cancer: is there a role for (18) FDG-PET?.  Oral Oncol. 2006;  42 275-280
    CrossrefPubMedGoogle Scholar
  • 193 Schöder H, Yeung H WD, Gonen M, Kraus D, Larson S M. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion.  Radiology. 2004;  231 65-72
    CrossrefPubMedGoogle Scholar
  • 194 Basu D, Siegel B A, McDonald D J, Nussenbaum B. Detection of occult bone metastases from head and neck squamous cell carcinoma - impact of positron emission tomography-computed tomography with fluorodeoxyglucose F 18.  Arch Otolaryngl Head Neck Surg. 2007;  133 801-805
    PubMedGoogle Scholar
  • 195 Fakhry N, Lussato D, Jacob T, Giorgi R, Giovanni A, Zanart M. Comparison between PET and PET/CT in recurrent head and neck cancer and clinical implications.  Eur Arch Otorhinolaryngol. 2007;  264 531-538
    CrossrefPubMedGoogle Scholar
  • 196 Ha P K, Hdeib A, Goldenberg D. et al . The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma.  Arch Otolaryngol Head Neck Surg. 2006;  132 12-16
    CrossrefPubMedGoogle Scholar
  • 197 Roh J L, Yeo N K, Kim J S, Cho K J, Choi S H, Nam S Y, Kim S Y. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.  Oral Oncol. 2007;  43 887-893
    CrossrefPubMedGoogle Scholar
  • 198 Ritoe S C, Bergman H, Krabbe P FM, Kaanders J HAM, van den Hoogen F JA, Verbeek A LM, Marres H AM. Cancer recurrence after total laryngectomy: treatment options, survival, and complications.  Head Neck. 2006;  28 383-388
    CrossrefPubMedGoogle Scholar
  • 199 Weaver B AA, Cleveland D W. Does aneuploidy cause cancer?.  Curr Opin Cell Biol. 2006;  18 658-667
    CrossrefPubMedGoogle Scholar
  • 200 Hanson J, Bruchmüller W, Nischwitz A S. Krebsvorstufen und die Früherkennung von Pharynx- und Larynx-Karzinomen.  Arch Geschwulstforschung. 1989;  59 99-105
    PubMedGoogle Scholar
  • 201 Böcking A, Stockhausen J, Meyer-Ebrecht D. Towards a single cell cancer diagnosis - multimodal and monocellular measurements of markers and morphology (5M).  Cell Oncol. 2004;  26 73-79
    PubMedGoogle Scholar
  • 202 Tárnok A, Gerstner A. Clinical applications of laser-scanning cytometry.  Cytometry (Clin Cytometry). 2002;  50 133-143
    PubMedGoogle Scholar
  • 203 Patente: DE 1 815 352 (1968), GB 1 300 585, US 3,738,759. 
    Google Scholar
  • 204 Göhde W, Dittrich W. Simultane Impulsfluorimetrie des DNS- und Proteingehaltes von Tumorzellen.  Z Anal Chem. 1970;  252 328-330
    CrossrefPubMedGoogle Scholar
  • 205 Kraus H, Bremke U, Wedding C. Ultraschnelle Messungen der DNS-Fluoreszenz an normalen Geweben, Entzündungen und Tumoren von Kopf und Hals. Archiv klin. exp.  Ohren-, Nasen-, und Kehlkopfheilk. 1972;  202 698-699
    PubMedGoogle Scholar
  • 206 Holm L E. Cellular DNA amount of squamous cell carcinomas of the head and neck region in relation to prognosis.  Laryngoscope. 1982;  92 1064-1069
    PubMedGoogle Scholar
  • 207 Wang X L, Chen R M, Wang Z S, Chen W L, Zuo L F. Flow cytometric DNA-ploidy as a prognostic indicator in oral squamous cell carcinoma.  Chin Med J. 1990;  103 572-575
    PubMedGoogle Scholar
  • 208 Hemmer J, Kreidler J. Flow cytometric DNA ploidy analysis of squamous cell carcinoma of the oral cavity - comparison with clinical staging and histologic grading.  Cancer. 1990;  66 317-320
    CrossrefPubMedGoogle Scholar
  • 209 Bueno P R, Gias L N, Delgado R G, Cebollada J D, Díaz González F J. Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the oral cavity and tongue base.  Head Neck. 1998;  20 232-239
    CrossrefPubMedGoogle Scholar
  • 210 Hemmer J, Kraft K, Kreidler J. The significance of DNA flow cytometry in predicting survival and delayed clinical manifestation of occult lymph node metastasis to the untreated neck in patients with oral squamous cell carcinoma.  J Cranio Maxillofac Surg. 1998;  26 405-410
    PubMedGoogle Scholar
  • 211 Ruá S, Comino A, Fruttero A, Cera G, Semeria C, Lanzillotty L, Boffetta P. Relationship between histologic features, DNA flow cytometry, and clinical behavior of squamous cell carcinomas of the larynx.  Cancer. 1991;  67 141-149
    CrossrefPubMedGoogle Scholar
  • 212 Walter M A, Peters G E, Peiper S C. Predicting radioresistance in early glottic squamous carcinoma by DNA content.  Ann Otol Rhinol Laryngol. 1991;  100 523-526
    PubMedGoogle Scholar
  • 213 Golusinski W, Olofsson J, Szmeja Z, Biczysko W, Krygier-Stojatowska A, Kulczynski B. A comprehensive analysis of selected diagnostic methods with respect to their usefulness in evaluating the biology of neoplastic cells in patients with laryngeal cancer.  Eur Arch Otorhinolaryngol. 1999;  256 306-311
    CrossrefPubMedGoogle Scholar
  • 214 Höfken F, Welkoborsky H J, Jacob R, Mann W. DNA-zytometrische Untersuchungen von Mund- und Rachenspülflüssigkeit als Screening-Verfahren zur Diagnose von Malignomen der Mundhöhle und der Oropharynx.  Laryngo Rhino Otol. 1995;  74 678-683
    PubMedGoogle Scholar
  • 215 Remmerbach T W, Weidenbach H, Pomjanski N, Knops K, Mathes S, Hemprich A, Böcking A. Cytologic and DNA-cytometric early diagnosis of oral cancer.  Anal Cell Pathol. 2001;  22 211-221
    PubMedGoogle Scholar
  • 216 Gerstner A OH, Thiele A, Tárnok A, Tannapfel A, Weber A, Bootz F. Prediction of upper aerodigestive tract cancer by slide-based cytometry.  Cytometry Part A. 2006;  69A 582-587
    CrossrefPubMedGoogle Scholar
  • 217 Gerstner A OH, Müller A K, Machlitt J, TaŽrnok A, Tannapfel A, Weber A, Bootz F. Slide-based cytometry for predicting malignancy in solid salivary gland tumors by fine needle aspirate biopsies.  Cytometry Part B (Clin Cytometry). 2003;  53B 20-25
    PubMedGoogle Scholar
  • 218 Gerstner A OH, Thiele A, Tárnok A, Machlitt J, Oeken J, Tannapfel A, Weber A, Bootz F. Preoperative detection of laryngeal cancer in mucosal swabs by slide-based cytometry.  Eur J Cancer. 2005;  41 445-452
    CrossrefPubMedGoogle Scholar
  • 219 Gerstner A OH, Machlitt J, Welkoborsky H J, Bootz F, Tárnok A. Analysis of ploidy in hypopharyngeal cancer by laser scanning cytometry on fine needle aspirate biopsies.  Anal Cell Pathol. 2003;  25 51-62
    PubMedGoogle Scholar
  • 220 Gerstner A OH, Gutsche M, Bücheler M, Machlitt J, Emmrich F, Sommerer F, Tárnok A, Bootz F. Eosinophilia in nasal polyposis: its objective quantification and clinical relevance.  Clin Exp Allerg. 2004;  34 65-70
    PubMedGoogle Scholar
  • 221 Remmerbach T W, Weidenbach H, Hemprich A, Böcking A. Earliest detection of oral cancer using non-invasive brush biopsy including DNA-image-cytometry: report on four cases.  Anal Cell Pathol. 2004;  25 159-166
    PubMedGoogle Scholar
  • 222 Leoni-Parvex S, Mihaescu A, Pellanda A, Monnier P, Bosman F T. Esophageal cytology in the follow-up of patients with treated upper aerodigestive tract malignancies.  Cancer. 2000;  90 10-16
    CrossrefPubMedGoogle Scholar
  • 223 Hutchinson M L, Cassin C M, Ball H G. The efficacy of an automated preparation device for cervical cytology.  Am J Clin Pathol. 1991;  96 300-305
    PubMedGoogle Scholar
  • 224 Klinkhamer P JJM, Meerding W J, Rosier P FWM, Hanselaar A GJM. Liquid-based cervical cytology - a review of the literature with methods of evidence-based medicine.  Cancer (Cancer Cytopathol). 2003;  99 263-271
    CrossrefPubMedGoogle Scholar
  • 225 Bollmann R, Bankfalvi A, Griefingholt H, Trosic A, Speich N, Schmitt C, Bollmann N. Validity of combined cytology and human papillomavirus (HPV) genotyping with adjuvant DNA-cytometry in routine cervical screening: results from 31 031 women from the Bonn-region in West Germany.  Oncol Rep. 2005;  13 915-922
    PubMedGoogle Scholar
  • 226 Bollmann M, Heller H, Bánkfalvi A, Griefingholt H, Bollmann R. Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer?.  Br J Urol. 2005;  95 1219-1225
    PubMedGoogle Scholar
  • 227 Gerstner A OH, Trumpfheller C, Racz P, Osmancik P, Tenner-Racz K, Tárnok A. Quantitative histology by multicolor slide-based cytometry.  Cytometry Part A. 2004;  59A 210-219
    PubMedGoogle Scholar
  • 228 Rubin M A, Zerkowski M P, Camp R L, Kuefer R, Hofer M D, Chinnaiyan A M, Rimm D L. Quantitative determination of expression of the prostate cancer protein α-Methylacyl-CoA racemase using automated quantitative analysis (AQUA) - a novel paradigm for automated and continuous biomarker measurements.  Am J Pathol. 2004;  164 831-840
    PubMedGoogle Scholar
  • 229 Taylor C R, Levenson R M. Quantification of immunohistochemistry - issues concerning methods, utility and semiquantitative assessment II.  Histopathology. 2006;  49 411-424
    CrossrefPubMedGoogle Scholar
  • 230 de Solórzano C O, Costes S, Callahan D E, Parvin B, Barcellos-Hoff M H. Applications of quantitative digital image analysis to breast cancer research.  Microscop Res Tech. 2002;  59 119-127
    PubMedGoogle Scholar
  • 231 Ludwig J A, Weinstein J N. Biomarkers in cancer staging, prognosis and treatment selection.  Nature Rev Cancer. 2005;  5 845-856
    CrossrefPubMedGoogle Scholar
  • 232 Issaq H J, Veenstra T D, Conrads T P, Felschow D. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification.  Biochem Biophys Res Comm. 2002;  292 587-592
    CrossrefPubMedGoogle Scholar
  • 233 Wadsworth J T, Somers K D, Stack B C, Cazares L, Malik G, Adam B L, Wright G L, Semmes O J. Identification of patients with head and neck cancer using serum protein profiles.  Arch Otolaryngol Head Neck Surg. 2004;  130 98-104
    CrossrefPubMedGoogle Scholar
  • 234 Gourin C G, Xia Z S, Han Y, French A M, O’Rourke A K, Terris D J, Adam B L. Serum protein profile analysis in patients with head and neck squamous cell carcinoma.  Arch Otolaryngol Head Neck Surg. 2006;  132 390-397
    CrossrefPubMedGoogle Scholar
  • 235 Kopf E, Zharhary D. Antibody arrays - an emerging tool in cancer proteomics.  Int J Biochem Cell Biol. 2007;  39 1305-1317
    CrossrefPubMedGoogle Scholar
  • 236 Hudelist G, Pacher-Zavisin M, Singer C F, Holper T, Kubista E, Schreiber M, Manavi M, Bilban M, Czerwenka K. Use of high-throughput protein array for profiling of differentially expressed proteins in normal and malignant breast tissue.  Breast Cancer Res Treat. 2004;  86 281-291
    PubMedGoogle Scholar
  • 237 Hathaway B, Landsittel D P, Gooding W, Whiteside T L, Grandis J R, Siegfried J M, Bigbee W L, Ferris R L. Multiplexed analysis of serum cytokines as biomarkers in squamous cell carcinoma of head and neck patients.  Laryngocope. 2005;  115 522-527
    PubMedGoogle Scholar
  • 238 Linkov F, Lisovich A, Yurkovetsky Z. et al . Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.  Cancer Epidemiol Biomarkers Prev. 2007;  16 102-107
    CrossrefPubMedGoogle Scholar
  • 239 Ziober B L, Mauk M G, Falls E M, Chen Z, Ziober A F, Bau H H. Lab-on-a-chip for oral cancer screening and diagnosis.  Head Neck. 2008;  30 111-121
    CrossrefPubMedGoogle Scholar
  • 240 Virchow R. Cellularpathologie in ihrer Begründung auf physiologische und pathologische Gewebelehre - 20 Vorlesungen. Berlin; August Hirschwald 1858
    Google Scholar
  • 241 Valet G, Leary J F, Tárnok A. Cytomics - new technologies: towards a human cytome project.  Cytometry Part A. 2004;  59A 167-171
    PubMedGoogle Scholar
  • 242 Valet G, Valet M, Tschöpe D, Gabriel H, Rothe G, Kellerman W, Kahle H. White cell and thrombocyte disorders - standardized, self-learning flow cytometric list mode data classification with the CLASSIF1 program system.  Ann N Y Acad Sci. 1993;  20 233-251
    PubMedGoogle Scholar
  • 243 Valet G. Cytomics, the human cytome project and systems biology: top-down resolution of the molecular biocomplexity of organisms by single cell analysis.  Cell Prolif. 2005;  38 171-174
    CrossrefPubMedGoogle Scholar
  • 244 van Driel B EM, Valet G K, Lyon H, Hansen U, Song J Y, van Noorden C JF. Prognostic estimation of survival of colorectal cancer patients with the quantitative histochemical assay of G6PDH activity and the multiparameter classification program CLASSIF1.  Cytometry (Comm Clin Cytometry). 1999;  38 176-183
    PubMedGoogle Scholar
  • 245 Valet G, Repp R, Link H, Ehninger A, Gramatzki M. SHG-AML study group . Pretherapeutic identification of high-risk acute myeloid leukemia (AML) patients from immunophenotypic, cytogenetic, and clinical parameters.  Cytometry Part B (Clinical Cytometry). 2003;  53B 4-10
    PubMedGoogle Scholar
  • 246 Valet G. Cytomics: an entry to biomedical cell systems biology.  Cytometry Part A. 2005;  63A 67-68
    CrossrefPubMedGoogle Scholar
  • 247 Valet G. Cytomics as a new potential for drug discovery.  Drug Discov Today. 2006;  11 785-791
    CrossrefPubMedGoogle Scholar
  • 248 Bloching M, Stephan D, Agha-Mir-Salim P, Berghaus A, Lautenschläger C, Grummt T. Der Ames-Test als Biomarker.  HNO. 2001;  49 440-446
    CrossrefPubMedGoogle Scholar
  • 249 Righini C A, de Fraipont F, Timsit J F, Faure C, Brambilla E, Reyt E, Favrot M C. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence.  Clin Cancer Res. 2007;  13 1179-1185
    CrossrefPubMedGoogle Scholar
  • 250 Bloching M, Hofmann A, Berghaus A, Lautenschläger C, Grummt T. Mikrokerne als Biomarker zum Nachweis der Feldkanzerisierung im oberen Aerodigestivtrakt.  HNO. 2000;  48 444-450
    CrossrefPubMedGoogle Scholar
  • 251 Kamboj M, Mahajan S. Micronucleus - an upcoming marker of genotoxic damage.  Clin Oral Invest. 2007;  11 121-126
    CrossrefPubMedGoogle Scholar
  • 252 Hsu T C, Johnston D A, Cherry L M, Rmakissoon D, Schantz S P, Jessup J M, Winn R J, Shirley L, Furlong C. Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to enviromental carcinogenesis.  Int J Cancer. 1989;  43 403-409
    CrossrefPubMedGoogle Scholar
  • 253 Kleinsasser N H, Schmid K, Sassen A W, Harréus U A, Staudenmaier R, Folwaczny M, Glas J, Reichl F X. Cytotoxic and genotoxic effects of resin monomers in human salivary gland tissue and lymphocytes as assessed by the single cell microgel electrophoresis (COMET) assay.  Biomaterials. 2006;  27 1762-1770
    CrossrefPubMedGoogle Scholar
  • 254 Kleinsasser N H, Wallner B C, Kastenbauer E R, Muenzenrieder R K, Harréus U A. Comparing the genotoxic sensitivities of human peripheral blood lymphocytes and mucosa cells of the upper aerodigestive tract using the Comet assay.  Mutation Res. 2000;  467 21-30
    PubMedGoogle Scholar
  • 255 Olive P L, Durand R E, le Riche J, Olivotto I A, Jackson S M. Gel electrophoresis of individual cells to quantify hypoxic fraction in human breast cancers.  Cancer Res. 1993;  53 733-736
    PubMedGoogle Scholar
  • 256 Singh N P, McCoy M T, Tice R R, Scheider E L. A simple technique for quantitation of low levels of DNA damage in individual cells.  Exp Cell Res. 1988;  175 184-191
    CrossrefPubMedGoogle Scholar
  • 257 McKelvey-Martin V J, Green M HL, Schmezer P, Pool-Zobel P L, DeMeo M P, Collins A. The single cell gel electrophoresis assay (Comet assay): a European review.  Mutat Res. 1993;  288 47-63
    PubMedGoogle Scholar
  • 258 Voegeli R. Die Schillersche Jodprobe im Rahmen der Ösophagusdiagnostik (Vorläufige Mitteilung).  Pract Oto-Rhino-Laryngol. 1966;  28 230-239
    PubMedGoogle Scholar
  • 259 Connor M J, Sharma P. Chromoendoscopy and magnification endoscopy for diagnosing esophageal cancer and dysplasia.  Thorac Surg Clin. 2004;  14 87-94
    PubMedGoogle Scholar
  • 260 Dawsey S M, Fleischer D E, Wang G Q, Zhou B, Kidwell J A, Lu N, Lewin K J, Roth M J, Tio L, Taylor F R. Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China.  Cancer. 1998;  83 220-231
    CrossrefPubMedGoogle Scholar
  • 261 Muto M, Nakane M, Katada C, Sano Y, Ohtsu A, Esumi H, Ebihara S, Yoshida S. Squamous cell carcinoma in situ at oropharyngeal and hypopharyngeal mucosal sites.  Cancer. 2004;  101 1375-1381
    CrossrefPubMedGoogle Scholar
  • 262 Voo I, Mavrofrides E C, Puliafito C A. Clinical applications of optical coherence tomography for the diagnosis and management of macular diseases.  Ophthalmol Clin North Am. 2004;  17 21-31
    CrossrefPubMedGoogle Scholar
  • 263 Bibas A G, Podoleanu A G, Cucu R G, Bonmarin M, Dobre G M, Ward V MM, Odell E, Boxer A, Gleeson M J, Lackson D A. 3-D optical coherence tomography of the laryngeal mucosa.  Clin Otolaryngol. 2004;  29 713-720
    CrossrefPubMedGoogle Scholar
  • 264 Armstrong W B, Ridgway J M, Vokes D E. et al . Optical coherence tomography of laryngeal cancer.  Laryngoscope. 2006;  116 1107-1113
    CrossrefPubMedGoogle Scholar
  • 265 Kraft M, Lüerßen K, Lubatschowski H, Glanz H, Arens C. Technique of optical coherence tomography of the larynx during microlaryngoscopy.  Laryngoscope. 2007;  117 950-952
    CrossrefPubMedGoogle Scholar
  • 266 Xie T, Xie H, Fedder G K, Pan Y. Endoscopic optical coherence tomography with a modified microelectromechanical systems mirror for detection of bladder cancers.  Appl Optics. 2003;  42 6422-6426
    PubMedGoogle Scholar
  • 267 Wang Z, Lee C S, Waltzer W C, Liu J, Xie H, Yuan Z, Pan Y. In vivo bladder imaging with microelectromechanical-systems-based endoscopic spectral domain optical coherence tomography.  J Biomed Opt. 2007;  12 034 009
    PubMedGoogle Scholar
  • 268 Pan Y T, Wu Z L, Yuan Z J, Wang Z G, Dub C W. Subcellular imaging of epithelium with time-lapse optical coherence tomography.  J Biomed Opt. 2007;  12 050 504
    PubMedGoogle Scholar
  • 269 Watanabe A, Tsujie H, Taniguchi M, Hosokawa M, Fujita M, Sasaki S. Laryngoscopic detection of pharyngeal carcinoma in situ with narrowband imaging.  Laryngoscope. 2006;  116 650-654
    CrossrefPubMedGoogle Scholar
  • 270 Koenig F, González S, White W M, Lein M, Rajadhyaksha M. Near-infrared confocal laser scanning microscopy of bladder tissue in vivo.  Urology. 1999;  53 853-857
    CrossrefPubMedGoogle Scholar
  • 271 Dickensheets D L, Kino G S. Micromachined scanning confocal optical microscope.  Optics Letters. 1996;  21 764-766
    PubMedGoogle Scholar
  • 272 Koenig F, Knittel J, Stepp H. Diagnosing Cancer in Vivo.  Science. 2001;  292 1401-1403
    CrossrefPubMedGoogle Scholar
  • 273 Kiesslich R, Burg J, Vieth M. et al . Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo.  Gastroenterology. 2004;  127 706-713
    CrossrefPubMedGoogle Scholar
  • 274 Hoffman A, Goetz M, Vieth M, Galle P R, Neurath M F, Kiesslich R. Confocal laser endomicroscopy: technical status and current indications.  Endoscopy. 2006;  38 1275-1283
    Article in Thieme ConnectPubMedGoogle Scholar
  • 275 Just T, Stave J, Boltze C, Wree A, Kramp B, Guthoff R F, Pau H W. Laser scanning microscopy of the human larynx mucosa: a preliminary, ex vivo study.  Laryngoscope. 2006;  116 1136-1141
    CrossrefPubMedGoogle Scholar
  • 276 Harris A T. Spectral mapping tools from the earth sciences applied to spectral microscopy data.  Cytometry Part A. 2006;  69A 872-879
    CrossrefPubMedGoogle Scholar
  • 277 Farkas D L, Du C, Fisher G W, Lau C, Niu W, Wachman E S, Levenson R M. Non-invasive image acquisition and advanced processing in optical bioimaging.  Comput Med Imaging Graphics. 1998;  22 89-102
    CrossrefPubMedGoogle Scholar
  • 278 Yang P, Farkas D L, Kirkwood J M, Abernethy J L, Edington HD, Becker D. Macroscopic spectral imaging and gene expression analysis of the early stages of melanoma.  Mol Med. 1999;  5 785-794
    PubMedGoogle Scholar
  • 279 Farkas D L, Becker D. Applications of spectral imaging: detection and analysis of human melanoma and its precursors.  Pigment Cell Res. 2001;  14 2-8
    CrossrefPubMedGoogle Scholar
  • 280 McMurdy J W, Jay G D, Suner S, Trespalacios F M, Crawford G P. Diffuse reflectance spectra of the palpebral conjunctiva and its utility as a noninvasive indicator of total hemoglobin.  J Biomed Opt. 2006;  11 014 019
    PubMedGoogle Scholar
  • 281 Ecker R C, de Martin R, Steiner G E, Schmid J A. Application of spectral imaging microscopy in cytomics and fluorescence resonance energy transfer (FRET) analysis.  Cytometry Part A. 2004;  59A 172-181
    PubMedGoogle Scholar
  • 282 Chung A, Wachsmann-Hogiu S, Zhao T, Xiong Y, Joseph A, Farkas D L. Advanced optical imaging requiring no contrast agents - a new armamentarium for medicine and surgery.  Current Surg. 2005;  62 365-370
    PubMedGoogle Scholar
  • 283 Müller M G, Valdez T A, Georgakoudi I. et al . Spectroscopic detection and evaluation of morphologic and biochemical changes in early human oral carcinoma.  Cancer. 2003;  97 1681-1692
    CrossrefPubMedGoogle Scholar
  • 284 Chung A, Karlan S, Lindsley E, Wachsmann-Hogiu S, Farkas D L. In vivo cytometry: a spectrum of possibilities.  Cytometry Part A. 2006;  69A 142-146
    CrossrefPubMedGoogle Scholar
  • 285 Lindsley E, Wachman E S, Farkas D L. The hyperspectral imaging endoscope: a new tool for in vivo cancer detection.  Prog Biomed Opt Imaging. 2004;  5 75-82
    PubMedGoogle Scholar
  • 286 Adams C L, Kobets N, Meiklejohn G R, Millington O R, Grierson A M, Rush C M, Smith K M, Garside P. Tracking lymphocytes in vivo.  Arch Immunol Ther Exp. 2004;  52 173-187
    PubMedGoogle Scholar
  • 287 Boutrus S, Greiner C, Hwu D, Chan M, Kuperwaser C, Lin C P, Georgakoudi I. Portable two-color in vivo flow cytometer for real-time detection of fluorescently-labeled circulating cells.  J Biomed Opt. 2007;  12 020 507
    PubMedGoogle Scholar
  • 288 Novak J, Puoris’haag M. Two-color, doulbe-slit in vivo flow cytometer.  Opt Lett. 2007;  32 2993-2995
    CrossrefPubMedGoogle Scholar
  • 289 Zharov V P, Galanzha E I, Tuchin V V. In vivo photothermal flow cytometry: imaging and detection of individual cells in blood and lymph flow.  J Cell Biochem. 2006;  97 916-932
    CrossrefPubMedGoogle Scholar
  • 290 Zharov V P, Galanzha E I, Shashkov E V, Khlebtsov N G, Tuchin V V. In vivo photoacustic flow cytometry for monitoring of circulating single cancer cells and contrast agents.  Opt Lett. 2006;  31 3623-3625
    CrossrefPubMedGoogle Scholar
  • 291 He W, Wang H, Hartmann L C, Cheng J X, Low P S. In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry.  Proc Natl Acad Sci USA. 2007;  104 11 760-11 765
    PubMedGoogle Scholar
  • 292 Boissonnas A, Fetler L, Zeelenberg I S, Hugues S, Amigorena S. In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor.  J Exp Med. 2007;  204 345-356
    CrossrefPubMedGoogle Scholar
  • 293 Wessels J T, Busse A C, Mahrt J, Dullin C, Grabbe E, Mueller G A. In vivo imaging in experimental preclinical tumor research - a review.  Cytometry Part A. 2007;  71A 542-549
    CrossrefPubMedGoogle Scholar
  • 294 Levenson R M, Mansfield J R. Multispectral imaging in biology and medicine: slices of life.  Cytometry Part A. 2006;  69A 748-758
    CrossrefPubMedGoogle Scholar
  • 295 Shcherbo D, Merzlyak E M, Chepurnykh T V. et al . Bright far-red fluorescent protein for whole-body imaging.  Nature Methods. 2007;  4 741-746
    CrossrefPubMedGoogle Scholar
  • 296 Sahai E. Illuminating the metastatic process.  Nature Rev Cancer. 2007;  7 737-749
    CrossrefPubMedGoogle Scholar
  • 297 Kim S, Lim Y T, Soltesz E G. et al . Near-infrared fluorescence type II quantum dots for sentinel lymph node mapping.  Nature Biotech. 2004;  22 93-97
    CrossrefPubMedGoogle Scholar
  • 298 Gao X, Cui Y, Levenson R M, Chung L WK, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots.  Nature Biotech. 2004;  22 969-976
    CrossrefPubMedGoogle Scholar

PD Dr. Andreas O. H. Gerstner

Klinik und Poliklinik für Hals-Nasen-Ohren-Heilkunde/Chirurgie, Universitätsklinikum Bonn

Sigmund-Freud-Straße 25
53105 Bonn

Email: gerstaoh@web.de